Based on this finding, we propose a novel role of RUNX1 in the potential recruitment of inflammatory cells in NASH, because VEGF is known to aggravate endothelial cell chemokine production in vitro and in vivo and functions in the recruitment of monocytes and T cells [16]. The gene discussed is RUNX1; the disease is metabolic dysfunction-associated steatohepatitis.